Physician profile
Alexander Carlson
NPI 1548898588
$5,512.17
in general payments reported to CMS, 2019-2025
9 companies · $3,425 in 2025
The $3,425 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,087 · 2025: $3,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,383 · Travel and Lodging: $2,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,382.84 |
| Travel and Lodging | $2,129.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,866.54 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $1,202.69 | 2024-2025 | Proclaim, Durata, Eterna |
| Boston Scientific Corporation | $589.95 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbvie INC. | $514.81 | 2024-2025 | |
| Pfizer INC. | $138.27 | 2024-2025 | |
| Saluda Medical Americas, INC. | $69.00 | 2025 | Evoke |
| Lundbeck LLC | $68.93 | 2025 | Vyepti |
| Si-Bone, INC. | $44.80 | 2024 | |
| Convatec INC. | $17.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.